{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:02:21Z","timestamp":1795028541570,"version":"4.10.2"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Backgrounds<\/jats:title>\n                    <jats:p>Nonalcoholic fatty liver disease (NAFLD) exhibits a close association with osteoporosis. This work aims to assess the potential effects of NAFLD on the progression of osteopenia in animal models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Forty-eight C57BL\/6 female mice were randomly divided to wild-type (WT) group and high-fat diet (HFD) group. The corresponding detections were performed after sacrifice at 16, 24 and 32\u00a0weeks, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At 16\u00a0weeks, an remarkable increase in body weight and lipid aggregation in the hepatocytes of HFD group was observed compared to the WT group, while the bone structure parameters showed no significant difference. At 24\u00a0weeks, the levels of TNF-\u03b1 and IL-6 in NAFLD mice were significantly increased, while the level of osteoprotegerin mRNA in bone tissue was decreased, and the level of receptor activator of nuclear factor Kappa-B ligand mRNA was increased. Meanwhile, the function of osteoclasts was increased, and the bone microstructure parameters showed significant changes. At 32\u00a0weeks, in the HFD mice, the mRNA levels of insulin-like growth factor-1 (IGF-1), runt-related transcription factor 2, and osterix mRNA were reduced, while the insulin-like growth factor binding protein-1 (IGFBP-1) level was increased. Simultaneously, the osteoblast function was decreased, and the differences of bone structure parameters were more significant, showing obvious osteoporosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The bone loss in HFD mice is pronounced as NAFLD progresses, and the changes of the TNF-\u03b1, IL-6, IGF-1, and IGFBP-1 levels may play critical roles at the different stages of NAFLD in HFD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13018-023-04385-1","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T02:03:35Z","timestamp":1701396215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Association of TNF-\u03b1, IGF-1, and IGFBP-1 levels with the severity of osteopenia in mice with nonalcoholic fatty liver disease"],"prefix":"10.1186","volume":"18","author":[{"given":"Tong-Hao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Biao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Gang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Xin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-zhang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,1]]},"reference":[{"key":"4385_CR1","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.3748\/wjg.v23.i10.1747","volume":"23","author":"E Poggiogalle","year":"2017","unstructured":"Poggiogalle E, Donini LM, Lenzi A, et al. Nonalcoholic fatty liver disease connections with fat-free tissues: a focus on bone and skeletal muscle. World J Gastroenterol. 2017;23:1747\u201357.","journal-title":"World J Gastroenterol"},{"key":"4385_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.maturitas.2021.02.007","volume":"147","author":"SA Polyzos","year":"2021","unstructured":"Polyzos SA, Anastasilakis AD, Efstathiadou ZA, et al. Postmenopausal osteoporosis coexisting with other metabolic diseases: treatment considerations. Maturitas. 2021;147:19\u201325.","journal-title":"Maturitas"},{"key":"4385_CR3","doi-asserted-by":"publisher","first-page":"e12835","DOI":"10.1097\/MD.0000000000012835","volume":"97","author":"HJ Chen","year":"2018","unstructured":"Chen HJ, Yang HY, Hsueh KC, et al. Increased risk of osteoporosis in patients with nonalcoholic fatty liver disease: a population-based retrospective cohort study. Medicine. 2018;97:e12835.","journal-title":"Medicine"},{"key":"4385_CR4","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.diabet.2018.10.001","volume":"45","author":"A Mantovani","year":"2019","unstructured":"Mantovani A, Sani E, Fassio A, et al. Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes. Diabetes Metab. 2019;45:347\u201355.","journal-title":"Diabetes Metab"},{"key":"4385_CR5","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1146\/annurev.nutr.012809.104655","volume":"32","author":"SA Shapses","year":"2012","unstructured":"Shapses SA, Sukumar D. Bone metabolism in obesity and weight loss. Annu Rev Nutr. 2012;32:287\u2013309.","journal-title":"Annu Rev Nutr"},{"issue":"1","key":"4385_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s12887-022-03317-y","volume":"22","author":"S L\u00f3pez-Peralta","year":"2022","unstructured":"L\u00f3pez-Peralta S, Romero-Velarde E, V\u00e1squez-Garibay EM, et al. Bone mineral density and body composition in normal weight, overweight and obese children. BMC Pediatr. 2022;22(1):249.","journal-title":"BMC Pediatr"},{"key":"4385_CR7","doi-asserted-by":"publisher","first-page":"627","DOI":"10.4254\/wjh.v5.i11.627","volume":"5","author":"M Kaya","year":"2013","unstructured":"Kaya M, I\u015f\u0131k D, Be\u015fta\u015f R, Evliyao\u011flu O, et al. Increased bone mineral density in patients with nonalcoholic steatohepatitis. Word J Hepatol. 2013;5:627\u201334.","journal-title":"Word J Hepatol"},{"key":"4385_CR8","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1053\/gast.2001.27126","volume":"121","author":"AE Reid","year":"2001","unstructured":"Reid AE. Nonalcoholic steatohepatitis. Gastroenterology. 2001;121:710\u201323.","journal-title":"Gastroenterology"},{"key":"4385_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1472-6750-12-5","volume":"12","author":"LE Carter","year":"2012","unstructured":"Carter LE, Kilroy G, Gimble JM, et al. An improved method for isolation of RNA from bone. BMC Biotechnol. 2012;12:5.","journal-title":"BMC Biotechnol"},{"key":"4385_CR10","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00774-016-0807-2","volume":"35","author":"S Upala","year":"2017","unstructured":"Upala S, Jaruvongvanich V, Wijarnpreecha K, et al. Nonalcoholic fatty liver disease and osteoporosis: a systematic review and meta-analysis. J Bone Miner Metab. 2017;35:685\u201393.","journal-title":"J Bone Miner Metab"},{"key":"4385_CR11","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1017\/S0007114514000051","volume":"111","author":"J Gautam","year":"2014","unstructured":"Gautam J, Choudhary D, Khedgikar V, et al. Micro-architectural changes in cancellous bone differ in female and male C57BL\/6 mice with high-fat diet-induced low bone mineral density. Br J Nutr. 2014;111:1811\u201321.","journal-title":"Br J Nutr"},{"key":"4385_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.tox.2018.08.007","volume":"410","author":"X Li","year":"2018","unstructured":"Li X, Wang Z, Klaunig JE. Modulation of xenobiotic nuclear receptors in high-fat diet induced non-alcoholic fatty liver disease. Toxicology. 2018;410:199\u2013213.","journal-title":"Toxicology"},{"key":"4385_CR13","doi-asserted-by":"publisher","first-page":"2314769","DOI":"10.1155\/2018\/2314769","volume":"2018","author":"DZ Chen","year":"2018","unstructured":"Chen DZ, Xu QM, Wu XX, et al. The combined effect of nonalcoholic fatty liver disease and metabolic syndrome on osteoporosis in postmenopausal females in Eastern China. Int J Endocrinol. 2018;2018:2314769.","journal-title":"Int J Endocrinol"},{"issue":"1","key":"4385_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13293-018-0205-7","volume":"9","author":"Z Kurt","year":"2018","unstructured":"Kurt Z, Barrere-Cain R, LaGuardia J, et al. Tissue-specific pathways and networks underlying sexual dimorphism in non-alcoholic fatty liver disease. Biol Sex Differ. 2018;9(1):46.","journal-title":"Biol Sex Differ"},{"issue":"1","key":"4385_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12944-017-0572-9","volume":"16","author":"Z Chen","year":"2017","unstructured":"Chen Z, Yu R, Xiong Y, et al. A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease. Lipids Health Dis. 2017;16(1):203.","journal-title":"Lipids Health Dis"},{"key":"4385_CR16","first-page":"327","volume":"16","author":"A Hadinia","year":"2019","unstructured":"Hadinia A, Doustimotlagh AH, Goodarzi HR, et al. Circulating levels of pro-inflammatory cytokines in patients with nonalcoholic fatty liver disease and non-alcoholic steatohepatitis. Iran J Immunol. 2019;16:327\u201333.","journal-title":"Iran J Immunol"},{"issue":"4","key":"4385_CR17","doi-asserted-by":"publisher","first-page":"19225","DOI":"10.4238\/2015.December.29.32","volume":"14","author":"L Yan","year":"2015","unstructured":"Yan L, Hu R, Tu S, et al. Meta-analysis of association between IL-6 -634C\/G polymorphism and osteoporosis. Genet Mol Res. 2015;14(4):19225\u201332.","journal-title":"Genet Mol Res"},{"key":"4385_CR18","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3389\/fimmu.2019.00505","volume":"10","author":"TJ De Vries","year":"2019","unstructured":"De Vries TJ, EI Bakkali I, Kamradt T, et al. What are the peripheral blood determinants for increased osteoclast formation in the various inflammatory diseases associated with bone loss. Front Immunol. 2019;10:505.","journal-title":"Front Immunol"},{"key":"4385_CR19","doi-asserted-by":"publisher","first-page":"6953421","DOI":"10.1155\/2020\/6953421","volume":"2020","author":"L Zhong","year":"2020","unstructured":"Zhong L, Yuan J, Huang L, et al. RANKL is involved in Runx2-triggered hepatic infiltration of macrophages in mice with NAFLD induced by a high-fat diet. Biomed Res Int. 2020;2020:6953421.","journal-title":"Biomed Res Int"},{"issue":"6","key":"4385_CR20","first-page":"1243","volume":"68","author":"M Nikseresht","year":"2021","unstructured":"Nikseresht M, Azarmehr N, Arya A. Circulating mRNA and plasma levels of osteoprotegerin and receptor activator of NF-\u03baB ligand in nonalcoholic fatty liver disease. Biotechnol Appl Biochem. 2021;68(6):1243\u20139.","journal-title":"Biotechnol Appl Biochem"},{"key":"4385_CR21","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.envpol.2019.03.027","volume":"249","author":"YJ Lv","year":"2019","unstructured":"Lv YJ, Wei QZ, Zhang YC, et al. Low-dose cadmium exposure acts on rat mesenchymal stem cells via RANKL\/OPG and downregulate osteogenic differentiation genes. Environ Pollut. 2019;249:620\u20138.","journal-title":"Environ Pollut"},{"issue":"6","key":"4385_CR22","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.cytogfr.2004.06.004","volume":"15","author":"S Theoleyre","year":"2004","unstructured":"Theoleyre S, Wittrant Y, Tat SK, et al. The molecular triad OPG\/RANK\/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev. 2004;15(6):457\u201375.","journal-title":"Cytokine Growth Factor Rev"},{"key":"4385_CR23","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/hepr.12408","volume":"45","author":"Y Sumida","year":"2015","unstructured":"Sumida Y, Yonei Y, Tanaka S, et al. Lower levels of insulin-like growth factor-1 standard deviation score are associated with histological severity of non-alcoholic fatty liver disease. Hepatol Res. 2015;45:771\u201381.","journal-title":"Hepatol Res"},{"key":"4385_CR24","doi-asserted-by":"publisher","first-page":"E138","DOI":"10.1152\/ajpendo.00107.2016","volume":"311","author":"J Svensson","year":"2016","unstructured":"Svensson J, Windahl SH, Saxon L, et al. Liver-derived IGF-I regulates cortical bone mass but is dispensable for the osteogenic response to mechanical loading in female mice. Am J Physiol Endocrinol Metab. 2016;311:E138\u201344.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4385_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00418-018-1640-6","volume":"149","author":"T Komori","year":"2018","unstructured":"Komori T. Runx2, an inducer of osteoblast and chondrocyte differentiation. Histochem Cell Biol. 2018;149:313\u201323.","journal-title":"Histochem Cell Biol"},{"issue":"4","key":"4385_CR26","first-page":"599","volume":"27","author":"Z Yuan","year":"2021","unstructured":"Yuan Z, Zhang T, Cai J. Research progress on the relationship between gut microbiota, IGF-1 and bone metabolism. Chin J Osteoporos. 2021;27(4):599\u2013604.","journal-title":"Chin J Osteoporos"},{"issue":"47","key":"4385_CR27","doi-asserted-by":"publisher","first-page":"E7554","DOI":"10.1073\/pnas.1607235113","volume":"113","author":"J Yan","year":"2016","unstructured":"Yan J, Herzog JW, Tsang K, et al. Gut microbiota induce IGF-1 and promote bone formation and growth. Proc Natl Acad Sci USA. 2016;113(47):E7554\u201363.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"4385_CR28","doi-asserted-by":"publisher","first-page":"5445","DOI":"10.3390\/ijms22115445","volume":"22","author":"WCW Chan","year":"2021","unstructured":"Chan WCW, Tan Z, To MKT, et al. Regulation and role of transcription factors in osteogenesis. Int J Mol Sci. 2021;22(11):5445.","journal-title":"Int J Mol Sci"},{"key":"4385_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jot.2022.01.002","volume":"33","author":"W Zhang","year":"2022","unstructured":"Zhang W, Wang N, Yang M. Periosteum and development of the tissue-engineered periosteum for guided bone regeneration. J Orthop Translat. 2022;33:41\u201354.","journal-title":"J Orthop Translat"},{"key":"4385_CR30","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1359\/jbmr.2002.17.11.1977","volume":"17","author":"K Sj\u00f6gren","year":"2002","unstructured":"Sj\u00f6gren K, Sheng M, Mov\u00e9rare S, et al. Effects of liver-derived insulin-like growth factor I on bone metabolism in mice. J Bone Miner Res. 2002;17:1977\u201387.","journal-title":"J Bone Miner Res"},{"key":"4385_CR31","first-page":"285","volume":"9","author":"M Binoux","year":"1996","unstructured":"Binoux M. Insulin-like growth factor binding proteins (IGFBPs): physiological and clinical implications. J Pediatr Endocrinol Metab. 1996;9:285\u20138.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"4385_CR32","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1080\/00365521.2017.1379556","volume":"52","author":"H Hagstr\u00f6m","year":"2017","unstructured":"Hagstr\u00f6m H, St\u00e5l P, Hultcrantz R, et al. IGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD-a pilot study. Scand J Gastroenterol. 2017;52:1427\u201334.","journal-title":"Scand J Gastroenterol"},{"key":"4385_CR33","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/1357-2725(96)00005-2","volume":"28","author":"KM Kelley","year":"1996","unstructured":"Kelley KM, Oh Y, Gargosky SE, et al. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol. 1996;28:619\u201337.","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"4385_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00223-016-0152-4","volume":"99","author":"H Lundin","year":"2016","unstructured":"Lundin H, S\u00e4\u00e4f M, Strender LE, et al. High serum insulin-like growth factor-binding protein 1 (IGFBP-1) is associated with high fracture risk independent of insulin-like growth factor 1 (IGF-I). Calcif Tissue Int. 2016;99(4):333\u20139.","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"4385_CR35","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1113\/EP088351","volume":"105","author":"SY Lee","year":"2020","unstructured":"Lee SY, Fam KD, Chia KL, et al. Age-related bone loss is associated with FGF21 but not IGFBP1 in healthy adults. Exp Physiol. 2020;105(4):622\u201331.","journal-title":"Exp Physiol"},{"key":"4385_CR36","first-page":"1343","volume":"32","author":"M Hussain","year":"2019","unstructured":"Hussain M, Iqbal J, Malik SA, et al. Effect of vitamin D supplementation on various parameters in non-alcoholic fatty liver disease patients. Pak J Pharm Sci. 2019;32:1343\u20138.","journal-title":"Pak J Pharm Sci"},{"key":"4385_CR37","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.3346\/jkms.2015.30.12.1821","volume":"30","author":"EJ Chang","year":"2015","unstructured":"Chang EJ, Yi DY, Yang HR. Vitamin D status and bone mineral density in obese children with nonalcoholic fatty liver disease. J Korean Med Sci. 2015;30:1821\u20137.","journal-title":"J Korean Med Sci"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-023-04385-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-023-04385-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-023-04385-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T02:05:32Z","timestamp":1701396332000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-023-04385-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4385"],"URL":"https:\/\/doi.org\/10.1186\/s13018-023-04385-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3257163\/v1","asserted-by":"object"}]},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,1]]},"assertion":[{"value":"12 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"915"}}